161 related articles for article (PubMed ID: 157239)
21. Glomerular fibrinolytic activity during nephrotoxic nephritis.
Giroux L; Verroust P; Morel-Maroger L; Delarue F; Delauche M; Sraer JD
Lab Invest; 1979 Apr; 40(4):415-22. PubMed ID: 431041
[TBL] [Abstract][Full Text] [Related]
22. Mediator systems in a passive model of in situ immune complex glomerulonephritis. Role for complement, polymorphonuclear granulocytes and monocytes.
Thaiss F; Batsford S; Mihatsch MJ; Heitz PU; Bitter-Suermann D; Vogt A
Lab Invest; 1986 Jun; 54(6):624-35. PubMed ID: 2940417
[TBL] [Abstract][Full Text] [Related]
23. Macrophage-induced glomerular injury. Cell transfer studies in passive autologous antiglomerular basement membrane antibody-initiated experimental glomerulonephritis.
Holdsworth SR; Neale TJ
Lab Invest; 1984 Aug; 51(2):172-80. PubMed ID: 6611452
[TBL] [Abstract][Full Text] [Related]
24. The interaction of anti-glomerular basement membrane antibody deposition with immune elimination of bovine serum albumin in the rabbit.
Trevillian P; Cameron JS
Clin Exp Immunol; 1979 Mar; 35(3):338-49. PubMed ID: 378480
[TBL] [Abstract][Full Text] [Related]
25. Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria.
Hara M; Batsford SR; Mihatsch MJ; Bitter-Suermann D; Vogt A
Lab Invest; 1991 Aug; 65(2):168-79. PubMed ID: 1881120
[TBL] [Abstract][Full Text] [Related]
26. Passive Heymann's nephritis as a model of immune glomerulonephritis mediated by antibodies to immunoglobulins.
Zanetti M; Druet P
Clin Exp Immunol; 1980 Aug; 41(2):189-95. PubMed ID: 7002394
[TBL] [Abstract][Full Text] [Related]
27. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
[TBL] [Abstract][Full Text] [Related]
28. A comparison of fibrinolytic and defibrinating agents in established experimental glomerulonephritis.
Tipping PG; Thomson NM; Holdsworth SR
Br J Exp Pathol; 1986 Aug; 67(4):481-91. PubMed ID: 3741774
[TBL] [Abstract][Full Text] [Related]
29. Procoagulant activity in glomeruli and urine of rabbits with nephrotoxic nephritis.
Wiggins RC; Glatfelter A; Brukman J
Lab Invest; 1985 Aug; 53(2):156-65. PubMed ID: 4021444
[TBL] [Abstract][Full Text] [Related]
30. [The effect of cyclosporin A on experimental glomerulonephritis in rabbits].
Kurunczi S; Dzengel M; Hosszu Z
Monatsschr Kinderheilkd; 1990 Apr; 138(4):211-5. PubMed ID: 2192271
[TBL] [Abstract][Full Text] [Related]
31. Kinetics of glomerular neutrophil influx after lipopolysaccharide in antibody-mediated injury.
Savige JA; Evans DJ; Rees AJ
Clin Exp Immunol; 1988 Jul; 73(1):134-8. PubMed ID: 3168328
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat.
Heeringa P; Brouwer E; Klok PA; Huitema MG; van den Born J; Weening JJ; Kallenberg CG
Am J Pathol; 1996 Nov; 149(5):1695-706. PubMed ID: 8909258
[TBL] [Abstract][Full Text] [Related]
33. [Study of several parameters of hemostasis in Masugi's rabbit nephritis].
Lagrue G; Levent M; Gouault-Heilmann M; Hirbec G; Branellec A
Pathol Biol (Paris); 1975 Feb; 23(2):139-44. PubMed ID: 1093104
[TBL] [Abstract][Full Text] [Related]
34. C3 dependent, C5 independent immune complex glomerulopathy in the mouse.
Sawtell NM; Hartman AL; Weiss MA; Pesce AJ; Michael JG
Lab Invest; 1988 Mar; 58(3):287-93. PubMed ID: 2964544
[TBL] [Abstract][Full Text] [Related]
35. Effects of ancrod and rtPA on fibrin accumulation, glomerular inflammation and renal function in nephrotoxic nephritis.
Mathieson PW; Thiru S; Peters DK; Oliveira DB
Int J Exp Pathol; 1991 Dec; 72(6):679-93. PubMed ID: 1768613
[TBL] [Abstract][Full Text] [Related]
36. Immune reactivity and immunosuppressive intervention (TLI) in experimental nephritis. I. Immunopathologic correlates in the accelerated autologous form of nephrotoxic serum nephritis.
Lowry RP; Forbes RD; Blackburn JH
J Immunol; 1984 Feb; 132(2):1001-6. PubMed ID: 6361128
[TBL] [Abstract][Full Text] [Related]
37. Antiglomerular basement membrane nephritis in the mouse. Study on the role of complement in the heterologous phase.
Schrijver G; Assmann KJ; Bogman MJ; Robben JC; de Waal RM; Koene RA
Lab Invest; 1988 Oct; 59(4):484-91. PubMed ID: 3050274
[TBL] [Abstract][Full Text] [Related]
38. The heterologous immune complex glomerulonephritis. A dose dependent glomerulonephritis with acute, latent and chronic phases in a long-term study.
Iversen BM; Matre R; Ofstad J
Acta Pathol Microbiol Immunol Scand C; 1982 Oct; 90(5):241-50. PubMed ID: 6217719
[TBL] [Abstract][Full Text] [Related]
39. Mediators for intraglomerular fibrin deposition in nephrotoxic serum nephritis.
Naish P; Evans DJ; Peters DK
J Urol Nephrol (Paris); 1974 Dec; 80(12):982. PubMed ID: 4459478
[No Abstract] [Full Text] [Related]
40. Mechanisms of glomerular injury in experimental immune nephritis. II. Effect of a platelet activating factor receptor antagonist in an autologous nephritis model.
Hruby ZW; Lowry RP; Forbes RD; Blais D
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):575-86. PubMed ID: 1668710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
